Chemoinformaics analysis of 1-(2-Furyl)propane-1,2-dione
| Molecular Weight | 138.122 | nRot | 2 |
| Heavy Atom Molecular Weight | 132.074 | nRig | 7 |
| Exact Molecular Weight | 138.032 | nRing | 1 |
| Solubility: LogS | -1.194 | nHRing | 1 |
| Solubility: LogP | 0.634 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 16 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 5 |
| nHA | 3 | APOL | 18.0968 |
| nHD | 0 | BPOL | 9.49124 |
| QED | 0.453 |
| Synth | 2.303 |
| Natural Product Likeliness | -0.633 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.038 |
| Pgp-sub | 0.001 |
| HIA | 0.006 |
| CACO-2 | -4.388 |
| MDCK | 0.0000228 |
| BBB | 0.141 |
| PPB | 0.853515 |
| VDSS | 0.76 |
| FU | 0.232413 |
| CYP1A2-inh | 0.928 |
| CYP1A2-sub | 0.556 |
| CYP2c19-inh | 0.314 |
| CYP2c19-sub | 0.112 |
| CYP2c9-inh | 0.111 |
| CYP2c9-sub | 0.215 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.205 |
| CYP3a4-inh | 0.008 |
| CYP3a4-sub | 0.217 |
| CL | 6.235 |
| T12 | 0.737 |
| hERG | 0.092 |
| Ames | 0.526 |
| ROA | 0.901 |
| SkinSen | 0.194 |
| Carcinogencity | 0.849 |
| EI | 0.994 |
| Respiratory | 0.908 |
| NR-Aromatase | 0.009 |
| Antiviral | No |
| Prediction | 0.897672 |